The cervical cancer vaccine has a high "reveal rate" recently. It can prevent HPV (human papilloma virus) mutations in the body. There are four main variants of this virus, two of which have a 75% chance of causing cervical cancer, and the other two have a 50% chance of inducing other reproductive system diseases. So how much is the hpv vaccine?

　　First, let''s confirm the "two major effects" of the HPV vaccine.

　　1. Cervical cancer risk can be reduced by 70-90％

　　Why can at least 70％ reduce cervical cancer risk? Because according to Statistics show that 70％ cervical cancer is caused by two subtypes of HPV16 and HPV18 in the HPV virus family, which is the most high-risk subtype. Only two of the high-risk subtypes covered by the bivalent and tetravalent vaccines reduce the cancer risk of 70％. The nine-valent vaccine covers not only HPV16 and HPV18, but also 5 other high-risk subtypes, so it can reduce the cancer risk of 90％.

　　 2. The risk of condyloma acuminatum can be reduced by 90％

　　 Although low-risk subtypes are not carcinogenic, the skin diseases caused by condyloma acuminatum are also head Big. For details, you can see the most insignificant skin disease caused by HPV infection in the past: condyloma acuminatum This is the preventive efficacy category of the four-valent and nine-valent vaccines, because these two vaccines cover the two low-risk subtypes of HPV6 and HPV11, 90％ ; Condyloma acuminata is related to both.

　　 Then, let''s confirm the price of the vaccine and whether it can achieve a satisfactory price-performance ratio. Let us first see whether the price can be accepted.

　　Quavalent vaccine (Mainland price): about 2500 RMB/3 shots, 9-valent vaccine (Hong Kong price): about 5000 RMB/3 shots

　　Nine-valent vaccine has excellent preventive efficacy As for the fourth price, the current international promotion is also higher than the fourth price, but the price is not everyone can afford.

Why is the price of the HPV vaccine so high? Because it is a cancer vaccine.

　　The development cost of cancer vaccines is high, which determines the market price. The effectiveness of the vaccine is measured by cervical epithelial lesions (precancerous lesions), or how much cancer occurs. Viral infection-precancerous lesions-malignant tumors, the three stages need to go through at least 10 years. In addition, clinical research requires trial and error, which consumes a lot of time cost and money cost.